This is a $1,254.83 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 units of the medication lisdexamfetamine 30 mg capsules. The contract has a performance period ending on June 12, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a $4,502.82 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 100-count bottles of the prescription drug lisdexamfetamine 20 mg capsules. The contract has an ultimate completion date of July 8, 2025 and is not set aside for any particular business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA...
This is a $3,264.08 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the medication lisdexamfetamine 20 mg capsules in 90-count packages. The order has a completion date of July 7, 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
This is a $2,140.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,979,063 units of 30mg lisdexamfetamine capsules, a prescription medication. The contract has an ultimate completion date of January 21, 2025 and was awarded on January 17, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held...
This is a $1,070.16 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 units of the drug lisdexamfetamine 20mg capsules, with a period of performance through May 28, 2025. This order is not associated with a set-aside program and was competed openly. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite...
This is a $3,756.77 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 100-count bottles of the prescription drug lisdexamfetamine 30 mg capsules. The contract has an ultimate completion date of July 8, 2025 and is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and holds a significant $999,999,999.00 Indefinite...
This is a $1,160.12 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 units of the prescription medication lisdexamfetamine 40 mg capsules. It has an ultimate completion date of July 2, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a $3,436.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 100 capsules of the prescription medication lisdexamfetamine 20 mg. The contract has an ultimate completion date of July 3, 2025 and is not set aside for any socioeconomic category. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of lisdexamfetamine 70 mg capsules in 100-count packages, with a ceiling value of $2,157.67 and a performance period ending on June 27, 2025. This award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,790.56 firm fixed-price delivery order is for the supply of 100 capsules of the prescription medication Lisdexamfetamine 50 mg. The contract has an ultimate completion date of April 30, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...